ES8800267A1 - Un metodo para obtener un peptido biologicamente activo que tiene afinidad para un ligando proteinaceo o su receptor - Google Patents

Un metodo para obtener un peptido biologicamente activo que tiene afinidad para un ligando proteinaceo o su receptor

Info

Publication number
ES8800267A1
ES8800267A1 ES557189A ES557189A ES8800267A1 ES 8800267 A1 ES8800267 A1 ES 8800267A1 ES 557189 A ES557189 A ES 557189A ES 557189 A ES557189 A ES 557189A ES 8800267 A1 ES8800267 A1 ES 8800267A1
Authority
ES
Spain
Prior art keywords
nucleotides
affinity
receptor
biologically active
active peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557189A
Other languages
English (en)
Other versions
ES557189A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
University of Texas at Austin
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/708,001 external-priority patent/US4863857A/en
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of ES557189A0 publication Critical patent/ES557189A0/es
Publication of ES8800267A1 publication Critical patent/ES8800267A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695—Corticotropin [ACTH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

METODO DE PREPARAR UN PEPTIDO BIOLOGICAMENTE ACTIVO QUE TIENE AFINIDAD PARA UN LIGANDO PROTEINACEO O SU RECEPTOR. COMPRENDE: A) AVERIGUAR UNA SEGUNDA SECUENCIA DE NUCLEOTIDOS DE UNA SEGUNDA CADENA DE NUCLEOTIDOS QUE TIENE UN APAREAMIENTO DE BASE CON UNA PRIMERA CADENA DE NUCLEOTIDOS QUE CODIFICA UNA PORCION DE COMPONENTE PROTENACEO DE UN LIGANDO PEPTIDO; B) DETERMINAR EN EL LIGANDO PEPTIDICO EN CASO DE APAREAMIENTO DE LA SEGUNDA SECUENCIA DE NUCLEOTIDOS CON LA SECUENCIA DE NUCLEOTIDOS DEL LIGANDO, LAS SECUENCIAS DE AMINOACIDOS HOMOLOGAS A LAS SECUENCIAS DE AMINOACIDOS CODIFICADOS POR LOS NUCLEOTICOS; Y C) PREPARAR UN POLIPEPTIDO CON UNA PORCION DE LAS SECUENCIAS HOMOLOGADAS. SE UTILIZA PARA FABRICAR PENICILINAS SINTETICAS. A
ES557189A 1985-03-01 1986-11-03 Un metodo para obtener un peptido biologicamente activo que tiene afinidad para un ligando proteinaceo o su receptor Expired ES8800267A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/708,001 US4863857A (en) 1985-03-01 1985-03-01 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
US06/829,709 US5077195A (en) 1985-03-01 1986-02-19 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor

Publications (2)

Publication Number Publication Date
ES557189A0 ES557189A0 (es) 1987-11-01
ES8800267A1 true ES8800267A1 (es) 1987-11-01

Family

ID=27108003

Family Applications (3)

Application Number Title Priority Date Filing Date
ES552534A Expired ES8705919A1 (es) 1985-03-01 1986-02-28 Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.
ES557188A Expired ES8800266A1 (es) 1985-03-01 1986-11-03 Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original
ES557189A Expired ES8800267A1 (es) 1985-03-01 1986-11-03 Un metodo para obtener un peptido biologicamente activo que tiene afinidad para un ligando proteinaceo o su receptor

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES552534A Expired ES8705919A1 (es) 1985-03-01 1986-02-28 Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.
ES557188A Expired ES8800266A1 (es) 1985-03-01 1986-11-03 Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original

Country Status (18)

Country Link
US (2) US5077195A (es)
EP (2) EP0332225B1 (es)
JP (1) JPH07215999A (es)
KR (1) KR920002315B1 (es)
AT (2) ATE63138T1 (es)
AU (1) AU592781B2 (es)
BR (1) BR8606615A (es)
CA (1) CA1339606C (es)
DE (2) DE3688333T2 (es)
DK (1) DK521386A (es)
ES (3) ES8705919A1 (es)
FI (1) FI90255C (es)
GR (1) GR860576B (es)
IE (1) IE58837B1 (es)
IL (1) IL96043A0 (es)
NO (1) NO174971C (es)
PT (1) PT82132B (es)
WO (1) WO1986005208A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0779717B2 (ja) * 1984-10-29 1995-08-30 マイクロジエニツクス コ−ポレ−シヨン タンパク質結合酵素相補性検定に関する方法
DE3527568A1 (de) * 1985-08-01 1987-02-05 Bissendorf Peptide Gmbh Synthetische peptidrezeptoren, verfahren zur herstellung und verwendung derselben
CA1297003C (en) * 1985-09-20 1992-03-10 Jack H. Nunberg Composition and method for treating animals
EP0294390A1 (en) * 1986-02-19 1988-12-14 Triton Biosciences Inc. Peptides affecting blood pressure regulation
US4772684A (en) * 1987-01-20 1988-09-20 Triton Biosciences, Inc. Peptides affecting blood pressure regulation
DK105289A (da) * 1988-03-04 1989-09-05 Univ Alabama Peptidaekvivalenter til ikke-peptider og fremgangsmaader til udformning af disse
EP0411503B1 (en) * 1989-07-31 1999-12-15 TECNOGEN Società Consortile per azioni Process for identifying and synthesizing binding sites of interacting proteins
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
JPH05262788A (ja) * 1991-09-03 1993-10-12 Hitachi Chem Co Ltd ペプチド類、その設計方法及び製造方法並びに受容体上の生理活性ペプチドの結合部位の決定方法
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
RU2145976C1 (ru) * 1993-10-04 2000-02-27 Сумитомо Кемикал Компани, Лимитед Способ получения полипептида (варианты)
EP0672421B1 (en) * 1993-10-07 2002-03-20 Kurashiki Boseki Kabushiki Kaisha Endothelin activity inhibitor
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
IL115177A0 (en) * 1994-09-16 1995-12-31 Immunomedics Inc Phosphorus-32 labeling of antibodies for cancer therapy
US5523208A (en) * 1994-11-30 1996-06-04 The Board Of Trustees Of The University Of Kentucky Method to discover genetic coding regions for complementary interacting proteins by scanning DNA sequence data banks
DE69627333T2 (de) * 1995-06-26 2004-02-12 PerSeptive Biosystems, Inc., Framingham Automatisierte, kontinuierliche mehrdimensionale hochgeschwindigkeitsmolekularselektion und -analyse
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
EP1039931B1 (en) * 1997-12-01 2005-04-27 Fang Fang Multivalent recombinant antibodies for treating hrv infections
DE19805334A1 (de) * 1998-02-11 1999-08-12 Otogene Biotechnologische Fors Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes
WO1999055911A1 (en) * 1998-04-24 1999-11-04 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (tclt)
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
ES2316356T3 (es) * 1999-03-09 2009-04-16 Fornix Biosciences N.V. Peptidos sinteticos complementarios y sus utilizaciones oftalmologicas.
GB2356401A (en) 1999-11-19 2001-05-23 Proteom Ltd Method for manipulating protein or DNA sequence data
GB9929466D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from microbial genome sequences
GB9929469D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from plant genomes
GB9929464D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligande generated from the human genome
WO2002027313A1 (en) * 2000-09-26 2002-04-04 Geneformatics, Inc. Methods for determining aproximations of three dimensional polypeptide structure
GB0025251D0 (en) * 2000-10-14 2000-11-29 Proteom Ltd Antisense peptides to Fc receptors and their uses
ATE488576T1 (de) * 2001-02-20 2010-12-15 Univ Georgia Schnellproduktion monoklonaler antikörper
WO2003062370A2 (en) 2001-07-19 2003-07-31 Perlan Therapeutics, Inc. Multimeric proteins and methods of making and using same
RU2422458C2 (ru) * 2006-03-23 2011-06-27 Кьюравак, Инк. Комплементарный пептид к основному иммуногенному району рецептора ацетилхолина, терапевтическая композиция на его основе, способ изготовления пептида и его применение
NZ614571A (en) * 2007-06-14 2014-12-24 Univ Oklahoma State Vaccines containing canine parvovirus genetic variants
US8227583B2 (en) 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
US20190062373A1 (en) * 2017-08-30 2019-02-28 Peption, LLC Method of generating interacting peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes

Also Published As

Publication number Publication date
NO174971B (no) 1994-05-02
FI864427A0 (fi) 1986-10-30
DK521386D0 (da) 1986-10-31
ES557189A0 (es) 1987-11-01
EP0332225B1 (en) 1993-04-21
KR870700100A (ko) 1987-02-28
ATE63138T1 (de) 1991-05-15
DE3688333T2 (de) 1993-10-28
EP0332225A3 (en) 1989-09-27
DK521386A (da) 1986-12-29
IE58837B1 (en) 1993-11-17
PT82132A (en) 1986-04-01
NO864369D0 (no) 1986-10-31
IE860527L (en) 1986-09-01
WO1986005208A1 (en) 1986-09-12
CA1339606C (en) 1997-12-30
FI864427A7 (fi) 1986-10-30
US5077195A (en) 1991-12-31
NO174971C (no) 1994-08-10
NO864369L (no) 1987-01-02
AU592781B2 (en) 1990-01-25
DE3688333D1 (de) 1993-05-27
US5212072A (en) 1993-05-18
DE3679017D1 (de) 1991-06-06
EP0214232B1 (en) 1991-05-02
ATE88572T1 (de) 1993-05-15
FI90255C (fi) 1994-01-10
PT82132B (pt) 1989-05-31
ES552534A0 (es) 1987-05-16
ES8705919A1 (es) 1987-05-16
GR860576B (en) 1986-07-01
EP0214232A1 (en) 1987-03-18
KR920002315B1 (ko) 1992-03-21
JPH07215999A (ja) 1995-08-15
EP0332225A2 (en) 1989-09-13
FI90255B (fi) 1993-09-30
AU5510286A (en) 1986-09-24
ES557188A0 (es) 1987-11-01
BR8606615A (pt) 1987-08-11
ES8800266A1 (es) 1987-11-01
IL96043A0 (en) 1991-07-18

Similar Documents

Publication Publication Date Title
ES8705919A1 (es) Un metodo para obtener un polipeptido complementario de al menos una porcion de un peptido o proteina original.
ES2196031T3 (es) Derivados peptidicos terapeutico.
ES2031806T3 (es) Factor de permeabilidad vascular humano.
ATE122357T1 (de) Polypeptide mit hormonwachstumsbefreiender wirkung.
DE3855536D1 (de) Rezeptoren für wachstumshormone
ES2120964T3 (es) Peptidos osteogenicos.
DK156592A (da) Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin
ES2093122T3 (es) Activacion mejorada de proteinas recombinantes.
ES552093A0 (es) Un procedimiento para sintetizar una secuencia de aminoacidos que contienen la totalidad o parte de la secuencia de aminoacidos de la preprorrelaxina -h2 humana.
ES2033678T3 (es) Procedimiento para la preparacion de una proteina de fusion.
ES2104596T3 (es) Nuevos polipeptidos, secuencias de adn que permiten su expresion, metodo de preparacion, y utilizacion.
AR246310A1 (es) Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante.
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
FI930626A0 (fi) Proteinstruktur hos vaexttoxingelonin
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
DK0707473T3 (da) Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler
ES2077674T3 (es) Aumento de la produccion de proteinas en animales.
ES2052391T3 (es) Derivados de acido 5-aminosalicilico para la terapia de enfermedades inflamatorias cronicas del intestino.
DK580886D0 (da) Dna-sekvens
SE9803962D0 (sv) Nucleic acid encoding a nervous tissue sodium channel
AR034853A1 (es) Secuencia de acido nucleico sintetico que codifica una alfa-galactosidasa, vector y celula que la comprenden, metodo para producir alfa-galactosidasa, metodo para prepararla, composicion farmaceutica que comprende dicha secuencia y su uso para preparar esta ultima
DK0717048T3 (da) Cyclohexapeptider og deres blandinger, fremgangsmåde til fremstilling deraf samt deres anvendelse
ES2060927T3 (es) Anticuerpos contra la fibrina; peptidos inmunogenos adecuados para preparar los anticuerpos, metodo para determinar fibrina y preparacion farmaceutica basada en los anticuerpos.
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980504